Back to Search
LAWRENCE CAMPO, M.D.
M.D.
Internal Medicine Physician
NPI: 1801884978Individual
Specialties, Licenses & Credentials
Internal Medicine PhysicianPrimary
Internal Medicine
Code: 207R00000X
ME58401(FL)
Research & Publications (20)
Quantification of 13 priority polycyclic aromatic hydrocarbons in human urine by headspace solid-phase microextraction gas chromatography-isotope dilution mass spectrometry.
PMID 19084626·Anal Chim Acta·2009
8-other
Self-collected urine sampling to study the kinetics of urinary toluene (and o-cresol) and define the best sampling time for biomonitoring.
PMID 19125274·Int Arch Occup Environ Health·2009
8-other
The key hypoxia regulated gene CAIX is upregulated in basal-like breast tumours and is associated with resistance to chemotherapy.
PMID 19165203·Br J Cancer·2009
8-other
Immunomodulation of FOXP3+ regulatory T cells by the aromatase inhibitor letrozole in breast cancer patients.
PMID 19188178·Clin Cancer Res·2009
8-other
Phosphorylated ERalpha, HIF-1alpha, and MAPK signaling as predictors of primary endocrine treatment response and resistance in patients with breast cancer.
PMID 19064988·J Clin Oncol·2009
3-trial
A novel headspace solid-phase microextraction method using in situ derivatization and a diethoxydiphenylsilane fibre for the gas chromatography-mass spectrometry determination of urinary hydroxy polycyclic aromatic hydrocarbons.
PMID 19523642·J Chromatogr A·2009
8-other
Urinary polycyclic aromatic hydrocarbons and monohydroxy metabolites as biomarkers of exposure in coke oven workers.
PMID 19221113·Occup Environ Med·2009
4-observational
Asthmatic symptoms after exposure to ethylenebisdithiocarbamates and other pesticides in the Europit field studies.
PMID 19042955·Hum Exp Toxicol·2008
4-observational
Expression of BNIP3 correlates with hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha and the androgen receptor in prostate cancer and is regulated directly by hypoxia but not androgens in cell lines.
PMID 18163427·Prostate·2008
8-other
Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
PMID 18451231·Clin Cancer Res·2008
2-rct
An integrated approach to biomonitoring exposure to styrene and styrene-(7,8)-oxide using a repeated measurements sampling design.
PMID 18608187·Biomarkers·2008
4-observational
Development of a gas chromatography/mass spectrometry method to quantify several urinary monohydroxy metabolites of polycyclic aromatic hydrocarbons in occupationally exposed subjects.
PMID 18952507·J Chromatogr B Analyt Technol Biomed Life Sci·2008
8-other
Biological monitoring and questionnaire for assessing exposure to ethylenebisdithiocarbamates in a multicenter European field study.
PMID 19042950·Hum Exp Toxicol·2008
4-observational
Prognostic significance of microvessel density and other variables in Japanese and British patients with primary invasive breast cancer.
PMID 17923874·Br J Cancer·2007
4-observational
Determination of low level methyl tert-butyl ether, ethyl tert-butyl ether and methyl tert-amyl ether in human urine by HS-SPME gas chromatography/mass spectrometry.
PMID 17386425·Anal Chim Acta·2007
4-observational
Application of ultraviolet spectrophotometry to estimate occupational exposure to airborne polyaromatic compounds in asphalt pavers.
PMID 17474031·J Occup Environ Hyg·2007
8-other
An investigation into the prognostic significance of necrosis and hypoxia in high grade and invasive bladder cancer.
PMID 17574616·J Urol·2007
8-other
Effects of folate cycle disruption by the green tea polyphenol epigallocatechin-3-gallate.
PMID 17683969·Int J Biochem Cell Biol·2007
8-other
Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer.
PMID 18096060·Breast Cancer Res·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3135 CITRUS TOWER BLVD
CLERMONT, FL 34711 - Phone
- (352) 988-6200
Quick Facts
- NPI
- 1801884978
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile